Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
文献类型：期刊论文
| 作者 | Ma,Liying1,2,3; Bian,Xing1,2,3; Lin,Wenchu1,3 |
| 刊名 | Journal of Experimental & Clinical Cancer Research
 |
| 出版日期 | 2021-01-05 |
| 卷号 | 40 |
| DOI | 10.1186/s13046-020-01805-6 |
| 通讯作者 | Lin,Wenchu(wenchu@hmfl.ac.cn) |
| 英文摘要 | An amendment to this paper has been published and can be accessed via the original article. |
| 语种 | 英语 |
| 出版者 | BioMed Central |
| WOS记录号 | BMC:10.1186/S13046-020-01805-6 |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/125701]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 通讯作者 | Lin,Wenchu |
| 作者单位 | 1.Chinese Academy of Sciences; Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science 2.University of Science and Technology of China 3.Chinese Academy of Sciences; High Magnetic Field Laboratory |
| 推荐引用方式 GB/T 7714 | Ma,Liying,Bian,Xing,Lin,Wenchu. Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer[J]. Journal of Experimental & Clinical Cancer Research,2021,40. |
| APA | Ma,Liying,Bian,Xing,&Lin,Wenchu.(2021).Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer.Journal of Experimental & Clinical Cancer Research,40. |
| MLA | Ma,Liying,et al."Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer".Journal of Experimental & Clinical Cancer Research 40(2021). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。